GPC1 and prostate cancer: Hence, our novel findings regarding the functions of GPC-1 in managing the intrinsic and extrinsic CAF phenotypes of BSCs in prostate cancer are important as they suggest GPC-1 as a novel anti-CAF target in prostate cancer.